Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – December 12, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases…

Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, December 12, 2018

Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, December 12, 2018   Conference Call and Webcast To be Held Wednesday, December 12, 2018at 4:30pm Eastern Time NEW YORK – December 10, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics…